Insilico Medicine (“Insilico”), a clinical-stage end-to-end generative artificial intelligence (AI) drug discovery company, has achieved a significant breakthrough in the application of multiple generative AI models and AlphaFold structures for drug discovery.
CDC to reduce funding for states’ child vaccination programs
The Centers for Disease Control and Prevention is reducing funding to states for child vaccination programs, according to an agency email obtained by KFF Health
July 8, 2023